The Hindu Business Line - Apr 16, 2009

Marck Biosciences, manufacturer of sterile dosages pharma products, announced its plan to enter the Singapore and Malaysian market. Marck said its manufacturing facility had received an approval from the NPCB (National Pharmaceutical Control Bureau), Ministry of Health, Malaysia for parenterals and opthalmics. Marck is the only company in india to have received the NPCB approval for its small volume parenterals facility.